Sho Tachino

542 total citations · 1 hit paper
6 papers, 410 citations indexed

About

Sho Tachino is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Sho Tachino has authored 6 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Sho Tachino's work include Renal and related cancers (2 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Sho Tachino is often cited by papers focused on Renal and related cancers (2 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Sho Tachino collaborates with scholars based in Japan, United States and Australia. Sho Tachino's co-authors include Yusaku Hori, Junji Matsui, Yu Kato, Kimiyo Tabata, Yasuhiro Funahashi, Yoichi Ozawa, K. Nomoto, Masahiro Matsuki, Ayako Yachie‐Kinoshita and Kazuhiko Yamada and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Molecular Cancer Therapeutics.

In The Last Decade

Sho Tachino

5 papers receiving 405 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway

2019 341 citations Yu Kato, Kimiyo Tabata et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sho Tachino Japan	5	258	123	112	104	92	6	410
Jonathan Derman France	6	300 1.2×	62 0.5×	206 1.8×	128 1.2×	60 0.7×	8	482
Zhongmin Maxwell Wang Australia	10	210 0.8×	27 0.2×	117 1.0×	70 0.7×	31 0.3×	17	330
Chuyu Jing China	13	212 0.8×	89 0.7×	61 0.5×	79 0.8×	23 0.3×	23	432
Benjamin Bonhomme France	8	131 0.5×	37 0.3×	35 0.3×	81 0.8×	46 0.5×	15	261
Ning‐Fu Peng China	12	150 0.6×	111 0.9×	21 0.2×	71 0.7×	30 0.3×	20	356
Quanren Wang China	1	245 0.9×	131 1.1×	67 0.6×	148 1.4×	82 0.9×	2	368
Holly Kemberling United States	7	471 1.8×	18 0.1×	99 0.9×	154 1.5×	185 2.0×	9	567
Laura Palmeri Italy	12	285 1.1×	34 0.3×	44 0.4×	130 1.3×	101 1.1×	20	390
Michael Sangmin Lee United States	9	266 1.0×	93 0.8×	45 0.4×	85 0.8×	124 1.3×	31	362

Countries citing papers authored by Sho Tachino

Since Specialization

Citations

This map shows the geographic impact of Sho Tachino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Tachino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Tachino more than expected).

Fields of papers citing papers by Sho Tachino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Tachino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Tachino. The network helps show where Sho Tachino may publish in the future.

Co-authorship network of co-authors of Sho Tachino

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Tachino. A scholar is included among the top collaborators of Sho Tachino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Tachino. Sho Tachino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kato, Yu, Kimiyo Tabata, Takayuki Kimura, et al.. (2019). Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway. PLoS ONE. 14(2). e0212513–e0212513. 341 indexed citations breakdown →

2.

Kato, Yu, Xiaoyi Bao, Kimiyo Tabata, et al.. (2016). Lenvatinib mesilate (LEN) enhanced antitumor activity of a PD-1 blockade agent by potentiating Th1 immune response. Annals of Oncology. 27. vi1–vi1. 33 indexed citations

3.

Kato, Yu, Kimiyo Tabata, Yusaku Hori, et al.. (2015). Abstract A92: Effects of lenvatinib on tumor-associated macrophages enhance antitumor activity of PD-1 signal inhibitors. Molecular Cancer Therapeutics. 14(12_Supplement_2). A92–A92. 13 indexed citations

4.

Lin, Yu‐Hung, Fumihiro Fujiki, Yoshitaka Oka, et al.. (2013). HLA-DPB1*05. Journal of Immunotherapy. 36(3). 159–170. 16 indexed citations

5.

Tachino, Sho, Fumihiro Fujiki, Yoshitaka Oka, et al.. (2012). Functional human Th17 clones with WT1-specific helper activity. Cancer Immunology Immunotherapy. 62(4). 801–810. 1 indexed citations

6.

Oka, Yoshitaka, Fumihiro Fujiki, Akihiro Tsuboi, et al.. (2012). Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor.. PubMed. 32(12). 5201–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact